Published in Proc Natl Acad Sci U S A on November 24, 1998
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J (2000) 3.59
The formation of skeletal muscle: from somite to limb. J Anat (2003) 3.37
cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci U S A (1999) 2.77
SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A (2004) 2.41
UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis. EMBO J (2010) 2.11
The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A (2004) 2.11
Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation. Genes Dev (1999) 2.08
Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol (1999) 1.96
The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci (2009) 1.51
Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration. Trends Cell Biol (2009) 1.49
Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype. Mol Cell Biol (2004) 1.39
Cooperation between myogenic regulatory factors and SIX family transcription factors is important for myoblast differentiation. Nucleic Acids Res (2010) 1.36
Eya1-Six1 interaction is sufficient to induce hair cell fate in the cochlea by activating Atoh1 expression in cooperation with Sox2. Dev Cell (2012) 1.30
Interplay between DNA methylation and transcription factor availability: implications for developmental activation of the mouse Myogenin gene. Mol Cell Biol (2010) 1.28
Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise. Biol Rev Camb Philos Soc (2010) 1.23
Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer. Mol Cell Biol (2004) 1.17
Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle. Epigenetics (2010) 1.17
Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-Dach2-myogenin signal transduction cascade. Proc Natl Acad Sci U S A (2006) 1.16
Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res (2010) 1.16
The Eyes Absent proteins in development and disease. Cell Mol Life Sci (2012) 1.16
Six proteins regulate the activation of Myf5 expression in embryonic mouse limbs. Proc Natl Acad Sci U S A (2007) 1.14
p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression. Mol Biol Cell (2002) 1.13
The Notch effector Hey1 associates with myogenic target genes to repress myogenesis. J Biol Chem (2009) 1.11
Six4, a putative myogenin gene regulator, is not essential for mouse embryonal development. Mol Cell Biol (2001) 1.05
Hypothalamic dysregulation and infertility in mice lacking the homeodomain protein Six6. J Neurosci (2011) 1.04
Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol (2012) 1.03
Epigenetic regulation of satellite cell activation during muscle regeneration. Stem Cell Res Ther (2011) 1.01
MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells. J Biol Chem (2010) 0.98
Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain. Oncogene (2006) 0.98
Molecular dissection of DNA sequences and factors involved in slow muscle-specific transcription. Mol Cell Biol (2001) 0.98
The EYA-SO/SIX complex in development and disease. Pediatr Nephrol (2012) 0.96
Direct control of the proneural gene atonal by retinal determination factors during Drosophila eye development. Dev Biol (2007) 0.96
Six homeoproteins directly activate Myod expression in the gene regulatory networks that control early myogenesis. PLoS Genet (2013) 0.95
Skeletal muscle repair in a mouse model of nemaline myopathy. Hum Mol Genet (2006) 0.95
Sipl1 and Rbck1 are novel Eya1-binding proteins with a role in craniofacial development. Mol Cell Biol (2010) 0.95
A highly conserved molecular switch binds MSY-3 to regulate myogenin repression in postnatal muscle. Genes Dev (2008) 0.94
Biochemical and functional characterization of six SIX1 Branchio-oto-renal syndrome mutations. J Biol Chem (2009) 0.93
Teashirt-3, a novel regulator of muscle differentiation, associates with BRG1-associated factor 57 (BAF57) to inhibit myogenin gene expression. J Biol Chem (2011) 0.92
Ski regulates muscle terminal differentiation by transcriptional activation of Myog in a complex with Six1 and Eya3. J Biol Chem (2008) 0.92
Skeletal myogenesis and Myf5 activation. Transcription (2011) 0.91
A conserved Six-Eya cassette acts downstream of Wnt signaling to direct non-myogenic versus myogenic fates in the C. elegans postembryonic mesoderm. Dev Biol (2009) 0.91
Turning on myogenin in muscle: a paradigm for understanding mechanisms of tissue-specific gene expression. Comp Funct Genomics (2012) 0.89
Discovery, optimization and validation of an optimal DNA-binding sequence for the Six1 homeodomain transcription factor. Nucleic Acids Res (2012) 0.88
Functional analysis of the homeodomain protein SIX5. Nucleic Acids Res (2000) 0.88
Diversity, phylogeny and expression patterns of Pou and Six homeodomain transcription factors in hydrozoan jellyfish Craspedacusta sowerbyi. PLoS One (2012) 0.87
Six1 regulates MyoD expression in adult muscle progenitor cells. PLoS One (2013) 0.87
Six1 regulates Grem1 expression in the metanephric mesenchyme to initiate branching morphogenesis. Dev Biol (2011) 0.87
Transcriptional analysis of the titin cap gene. Mol Genet Genomics (2011) 0.85
Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression. J Biomol Screen (2014) 0.85
Regulation of male sex determination: genital ridge formation and Sry activation in mice. Cell Mol Life Sci (2014) 0.83
Myocyte enhancer factor 2 activates promoter sequences of the human AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctate. Mol Cell Biol (2005) 0.82
Transcriptional regulation of cranial sensory placode development. Curr Top Dev Biol (2015) 0.82
Temperature affects methylation of the myogenin putative promoter, its expression and muscle cellularity in Senegalese sole larvae. Epigenetics (2013) 0.82
Transcriptome profiling in fast versus slow-growing rainbow trout across seasonal gradients. BMC Genomics (2016) 0.82
MyoD reprogramming requires Six1 and Six4 homeoproteins: genome-wide cis-regulatory module analysis. Nucleic Acids Res (2016) 0.80
Developmental expression patterns of candidate cofactors for vertebrate six family transcription factors. Dev Dyn (2010) 0.79
Microarray identification of novel genes downstream of Six1, a critical factor in cranial placode, somite, and kidney development. Dev Dyn (2014) 0.78
The role of Six1 in the genesis of muscle cell and skeletal muscle development. Int J Biol Sci (2014) 0.78
MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1. J Cell Sci (2014) 0.77
The Eye Specification Network in Drosophila. Proc Indian Natl Sci Acad B Biol Sci (2004) 0.77
Time course and side-by-side analysis of mesodermal, pre-myogenic, myogenic and differentiated cell markers in the chicken model for skeletal muscle formation. J Anat (2015) 0.77
Fine-tuning the onset of myogenesis by homeobox proteins that interact with the Myf5 limb enhancer. Biol Open (2015) 0.75
MyoD or Myf-5 is required for the formation of skeletal muscle. Cell (1993) 7.14
Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75
Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature (1993) 4.33
Six3, a murine homologue of the sine oculis gene, demarcates the most anterior border of the developing neural plate and is expressed during eye development. Development (1995) 3.90
The eye-specification proteins So and Eya form a complex and regulate multiple steps in Drosophila eye development. Cell (1997) 3.61
Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell (1997) 3.42
The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev (1993) 3.15
The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell (1993) 3.08
The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science (1989) 2.86
A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet (1997) 2.68
Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol Cell Biol (1992) 2.64
The Drosophila sine oculis locus encodes a homeodomain-containing protein required for the development of the entire visual system. Neuron (1994) 2.56
Homeobox genes and connective tissue patterning. Development (1995) 2.43
Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev (1997) 2.40
Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science (1993) 2.36
Mouse Eya homologues of the Drosophila eyes absent gene require Pax6 for expression in lens and nasal placode. Development (1997) 2.18
Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature (1996) 2.16
Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet (1997) 1.79
Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell (1997) 1.79
Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat Genet (1997) 1.76
Myogenin is required for late but not early aspects of myogenesis during mouse development. J Cell Biol (1995) 1.74
Mouse Eya genes are expressed during limb tendon development and encode a transcriptional activation function. Proc Natl Acad Sci U S A (1997) 1.61
A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet (1995) 1.39
A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle. Mol Cell Biol (1994) 1.29
Eye development: governed by a dictator or a junta? Cell (1997) 1.27
Identification and expression of six family genes in mouse retina. FEBS Lett (1996) 1.27
Cloning and characterization of two vertebrate homologs of the Drosophila eyes absent gene. Genome Res (1997) 1.25
Structure, function and expression of a murine homeobox protein AREC3, a homologue of Drosophila sine oculis gene product, and implication in development. Nucleic Acids Res (1996) 1.23
Tissue and developmental distribution of Six family gene products. Int J Dev Biol (1998) 1.21
The MEF-3 motif is required for MEF-2-mediated skeletal muscle-specific induction of the rat aldolase A gene. Mol Cell Biol (1993) 1.14
A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles. Mol Cell Biol (1997) 1.07
Cloning of the human SIX1 gene and its assignment to chromosome 14. Genomics (1996) 1.05
Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice. Mol Cell Biol (1996) 1.01
Fast-muscle-specific expression of human aldolase A transgenes. Mol Cell Biol (1994) 0.94
Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for unknown proteins. J Mol Biol (1995) 0.90
Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophy. Neuromuscul Disord (1996) 0.89
Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients. Biochem J (1993) 0.84
Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem (1996) 7.37
Transcription of the dystrophin gene in human muscle and non-muscle tissue. Nature (1988) 7.00
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A (2001) 5.77
Effect of Gibberellin on Germination of Lettuce Seed. Science (1957) 5.27
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
Characterization of glyoxysomes from castor bean endosperm. Plant Physiol (1968) 4.40
Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A (1989) 4.21
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol (1999) 4.06
A functionally conserved homolog of the Drosophila segment polarity gene hh is expressed in tissues with polarizing activity in zebrafish embryos. Cell (1993) 3.90
Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron (1999) 3.69
DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally. Cell (1990) 3.44
A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell (1998) 3.09
Cloning, dignity and ethical revisionism. Nature (1997) 3.02
Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol (1999) 2.88
Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Oncogene (2001) 2.63
Energy transfer between protochlorophyllide molecules: evidence for multiple chromophores in the photoactive protochlorophyllide-protein complex vivo and in vitro. J Mol Biol (1970) 2.52
Isolation and characterization of cDNA clones for human skeletal muscle alpha actin. Nucleic Acids Res (1983) 2.45
Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature (1998) 2.36
Prenatal exposure to cigarette smoking is associated with a decrease in arousal in infants. J Pediatr (1999) 2.36
Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science (1983) 2.28
Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med (1996) 2.26
tRNA(Glu) as a cofactor in delta-aminolevulinate biosynthesis: steps that regulate chlorophyll synthesis. Trends Biochem Sci (1988) 2.24
Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease. Am J Trop Med Hyg (1989) 2.15
Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A (2004) 2.03
A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet (2000) 1.97
Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet (1993) 1.95
Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol (2001) 1.88
Structure of the rat L-type pyruvate kinase gene. J Mol Biol (1987) 1.87
Glucose regulation of gene transcription. J Biol Chem (2000) 1.86
Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol Cell Biol (1997) 1.86
Growth and differentiation of C2 myogenic cells are dependent on serum response factor. Mol Cell Biol (1996) 1.82
Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP. Nucleic Acids Res (1992) 1.77
A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet (1999) 1.68
Proteins binding to the liver-specific pyruvate kinase gene promoter. A unique combination of known factors. J Mol Biol (1989) 1.66
Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem (1994) 1.64
Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem (1989) 1.64
Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J Biol Chem (1996) 1.64
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res (2001) 1.63
Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med (1997) 1.62
The influence of a pacifier on infants' arousals from sleep. J Pediatr (2000) 1.62
Possible role of phenothiazines in sudden infant death. Lancet (1979) 1.60
Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics (1991) 1.57
Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature (1990) 1.54
Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals. Clin Pharmacokinet (1998) 1.52
Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells. Eur J Biochem (1990) 1.52
Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. Am J Physiol (1996) 1.51
Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol (2001) 1.51
Biosynthesis of delta-aminolevulinate in greening barley leaves. IX. Structure of the substrate, mode of gabaculine inhibition, and the catalytic mechanism of glutamate 1-semialdehyde aminotransferase. Carlsberg Res Commun (1988) 1.50
Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression. Proc Natl Acad Sci U S A (2000) 1.46
The 'CC.Ar.GG' box. A protein-binding site common to transcription-regulatory regions of the cardiac actin, c-fos and interleukin-2 receptor genes. Eur J Biochem (1988) 1.44
Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J Biol Chem (1998) 1.41
Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med (2001) 1.41
Exploration of a liver-specific, glucose/insulin-responsive promoter in transgenic mice. J Biol Chem (1993) 1.41
Photoactive Subunits of Protochlorophyll(ide) Holochrome. Plant Physiol (1971) 1.39
Characterization of three optional promoters in the 5' region of the human aldolase A gene. J Mol Biol (1987) 1.37
Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J (1994) 1.36
Light-dependent absorption and selective scattering changes at 518 nm in chloroplast thylakoid membranes. Proc Natl Acad Sci U S A (1975) 1.35
LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med (1999) 1.35
Glucose-dependent liver gene expression in upstream stimulatory factor 2 -/- mice. J Biol Chem (1997) 1.34
Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J Biol Chem (1999) 1.34
Chemotactic response of monocytes to thrombin. J Cell Biol (1983) 1.33
Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver. J Biol Chem (1986) 1.31
Molecular cloning and sequence analysis of cDNA for human transferrin. Biochem Biophys Res Commun (1984) 1.30
Needle length and injection technique for efficient intramuscular vaccine delivery in infants and children evaluated through an ultrasonographic determination of subcutaneous and muscle layer thickness. Pediatrics (1997) 1.30
The 5'-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett (1998) 1.30
The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am J Hum Genet (1984) 1.30
Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res (1999) 1.29
Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes (2001) 1.28
Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther (1995) 1.27
Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat Genet (1993) 1.27
Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc Natl Acad Sci U S A (1985) 1.26
Genetic regulation of chlorophyll synthesis analyzed with mutants in barley. Science (1974) 1.26
A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease. J Biol Chem (1990) 1.25
Auditory arousal thresholds are higher when infants sleep in the prone position. J Pediatr (1998) 1.25
Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP. J Biol Chem (1999) 1.25
Deletion of the long arm of the Y chromosome and review of Y chromosome abnormalities. Am J Med Genet (1985) 1.24
Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. J Biol Chem (1994) 1.22
Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem (1995) 1.21
Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. J Biol Chem (1996) 1.20
The pyruvate kinase gene as a model for studies of glucose-dependent regulation of gene expression in the endocrine pancreatic beta-cell type. J Biol Chem (1993) 1.20
Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol Biol Cell (1996) 1.20
The structural gene for aldolase B (ALDB) maps to 9q13----32. Ann Hum Genet (1985) 1.19
Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet (2000) 1.19
Molecular cloning of cDNA for rat L-type pyruvate kinase and aldolase B. J Biol Chem (1983) 1.18
Assignment of the gene for F-type phosphofructokinase to human chromosome 10 by somatic cell hybridization and specific immunoprecipitation. Ann Hum Genet (1980) 1.17
Characterisation of a second patched gene in the zebrafish Danio rerio and the differential response of patched genes to Hedgehog signalling. Dev Biol (1999) 1.17
Functional characterization of the L-type pyruvate kinase gene glucose response complex. Mol Cell Biol (1993) 1.16
Regulation of left-right asymmetries in the zebrafish by Shh and BMP4. Dev Biol (1999) 1.16
Home monitoring of infants considered at risk for the sudden infant death syndrome. Four years' experience (1977-1981). Eur J Pediatr (1982) 1.15
Upstream stimulatory factor-2 (USF2) activity is required for glucose stimulation of L-pyruvate kinase promoter activity in single living islet beta-cells. J Biol Chem (1997) 1.14
Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. Proc Natl Acad Sci U S A (1992) 1.14
Expression of the transferrin gene during development of non-hepatic tissues: high level of transferrin mRNA in fetal muscle and adult brain. Biochem Biophys Res Commun (1984) 1.13
Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control. Ther Drug Monit (1993) 1.12